Directory
>
Heidi Colton
Heidi Colton
Executive Director, Nonclinical Development Strategy and Translational Medicine | Chimerix, Inc.
Apex, North Carolina, United States
Heidi Colton
Summary
Heidi Colton is an accomplished Executive Director with extensive experience in the pharmaceutical and biotechnology sectors, specializing in nonclinical and translational development strategies. Her career spans both big pharma and small biotech environments, where she has successfully led initiatives in antiviral, antibacterial, and oncology drug development. Heidi's expertise lies in designing translational medicine strategies and managing complex regulatory submissions, having independently delivered multiple nonclinical IND/NDA packages. She possesses strong leadership skills, having effectively guided international matrix teams towards achieving project goals. With a solid background in toxicology and pharmacovigilance, she is well-versed in clinical safety and risk management. Heidi is also recognized for her regulatory writing proficiency and has a hands-on laboratory experience that enhances her strategic insights. Her educational foundation includes a BS in Microbiology from Penn State University and further studies at North Carolina State University. Outside of her professional endeavors, Heidi is passionate about advancing the field of drug development through innovative biomarker strategies.
Heidi Colton
Work Experience
Executive Director, Nonclinical Development Strategy and Translational Medicine at
Chimerix, Inc.
January 2023 - Present
Executive Director, Toxicology & Translational Medicine at
Chimerix, Inc.
January 2021 - January 2023
Senior Director, Toxicology & Translational Medicine at
Chimerix, Inc.
January 2019 - January 2021
Director, Toxicology at
Chimerix, Inc.
December 2015 - January 2019
Associate Director, Toxicology at
Chimerix, Inc.
April 2015 - December 2015
Director, Investigative Toxicology at
GSK
January 2014 - April 2015
Clinical Safety Scientist - Global Clinical Safety and Pharmacovigilance at
GSK
January 2013 - September 2013
Senior Scientific Investigator- Nonclinical Safety Assessment at
GSK
January 2002 - January 2009
Scientist - Toxicogenomics- Nonclinical Safety Assessment at
GSK
January 2001 - January 2002
Associate Scientist- Microbiology, Pharmaceutical Development at
GSK
January 1996 - January 2001
Heidi Colton
Education
North Carolina State University
January 2000 - January 2002
January 1992 - January 1996
Frequently Asked Questions about Heidi Colton
What is Heidi Colton email address?
Heidi Colton's primary email address is *******@chimerix.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Heidi Colton work for?
Heidi Colton is a Executive Director, Nonclinical Development Strategy and Translational Medicine at Chimerix, Inc., a company specializing in Commercial physical research.
Where Heidi Colton graduated from?
Heidi Colton holds a degree in from North Carolina State University.
How can I directly contact Heidi Colton?
To contact Heidi Colton directly, you can use the email address *******@chimerix.com. Complete contact information is available upon registration with Muraena.
Who is Heidi Colton?
Heidi Colton is an accomplished Executive Director with extensive experience in the pharmaceutical and biotechnology sectors, specializing in nonclinical and translational development strategies. Her career spans both big pharma and small biotech environments, where she has successfully led initiatives in antiviral, antibacterial, and oncology drug development. Heidi's expertise lies in designing translational medicine strategies and managing complex regulatory submissions, having independently delivered multiple nonclinical IND/NDA packages. She possesses strong leadership skills, having effectively guided international matrix teams towards achieving project goals. With a solid background in toxicology and pharmacovigilance, she is well-versed in clinical safety and risk management. Heidi is also recognized for her regulatory writing proficiency and has a hands-on laboratory experience that enhances her strategic insights. Her educational foundation includes a BS in Microbiology from Penn State University and further studies at North Carolina State University. Outside of her professional endeavors, Heidi is passionate about advancing the field of drug development through innovative biomarker strategies.
Heidi`s contact details
*******@chimerix.com
**************@gsk.com
Colleagues
Executive Director of Quality Assurance
Vice President, Biostatistics
Member Board of Directors
Chief Scientific Officer
Executive Director, Human Resources
Vice President Regulatory Affairs
VP Clinical Pharmacology/Translational Medicine
Retired